Business article - November 20, 2020
A new Swedish cell and gene therapy company has been launched
Elicera Therapeutics has announced that it has completed its first share issue and secured SEK 13.2 million in financing. The company is based on research by professor Magnus Essand’s research group at Uppsala University and will focus on CAR T-cells and oncolytic viruses. “In the CAR T-cell space, we have two drug candidates under development […]
Biotech Business - October 6, 2020
Elicera Therapeutics has been launched and secures 13.2 MSEK
A new Swedish cell and gene therapy company, Elicera Therapeutics, has announced that it has completed its first share issue and secured 13.2 MSEK in financing. The company is based on research by professor Magnus Essand’s research group at Uppsala University and will focus on CAR T cells and oncolytic viruses. Four different drug candidates […]